Delivery Order SPE2DB22D1017-SPE2DB24FF6MU
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $32,672.79 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of August 2, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States, providing a wide range of medical commodities to federal agencies and...
- This federal contract award, valued at $38,691.31, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Dupixent 300 mg/2 ml pens to the government. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, to provide a wide range of pharmaceutical products and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $9,318.62 firm-fixed-price contract is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of September 20, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various federal agencies, including the DLA. The company holds several Indefinite Delivery...
- This federal contract award is a delivery order valued at $53,564.23 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The award, issued by the Defense Logistics Agency (DLA), is for the supply of the prescription medication Dupixent 300 mg/2 ml pen. The contract has a period of performance ending on September 25, 2024 and uses a firm fixed price pricing structure. Amerisourcebergen holds a broader indefinite delivery contract with the DLA Troop...
- This federal contract award is for the pharmaceutical product Dupixent 200 mg/1.14 ml pen, awarded to Amerisourcebergen Drug Corp's Corporate Office division. The $3,215.43 firm-fixed-price delivery order was issued by the Defense agency Medical Supply Chain, with a performance location in Conshohocken, Pennsylvania. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics Agency (DLA)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,511.90 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,980.54 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Dupixent 300 mg/2 ml syringes, with a period of performance through April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,418.92, is a delivery order for the supply of the specialty medication Dupixent 300 mg/2 ml pen. The contract has a completion date of December 9, 2024 and is a firm fixed-price contract. Amerisourcebergen is a for-profit organization and a registered vendor in the System for Award...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml pen, 2 ml, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $31,697.12 firm-fixed-price delivery order has a completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,905.39 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of June 10, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF6MUDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order valued at $5,322.07 for the supply of Dupixent 300 mg/2 ml pens. It has a firm fixed price and an ultimate completion date of April 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This includes specialty, brand name, generic, and over-the-counter medications, as well as critical care materials. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 4/23/24 |